Evolution AB/ SE0012673267 /
02/08/2024 15:03:19 | Chg. -29.50 | Volume | Bid15:03:35 | Ask15:03:35 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
1,005.50SEK | -2.85% | 152,091 Turnover: 84.46 mill. |
1,005.00Bid Size: 78 | 1,005.50Ask Size: 309 | 216.9 bill.SEK | - | - |
Newsfile Corp
30/07
Kenorland Enters Definitive Agreement to Sell the South Thompson Project to Evolution Nickel
Newsfile Corp
30/07
96M Partners with Evolution Gaming to Introduce Lightning Baccarat in Online Casino Singapore
Newsfile Corp
30/07
St. Kitts and Nevis Marks a Milestone in the Evolution of the Citizenship by Investment Programme wi...
GlobeNewswire
24/06
4DMT Announces FDA Clearance of IND Application for 4D-175 Genetic Medicine for the Treatment of Geo...
GlobeNewswire
21/06
Revolutionizing Gaming: Secret Casino Tips Release New Article on The Cutting-Edge Technologies Behi...
GlobeNewswire
20/06
Welsbach Technology Metals Acquisition Corp. Announces Extension Proposal and Non-Redemption Agreeme...
GlobeNewswire
19/06
OSE Immunotherapeutics Reports on its 2024 General Shareholders’ Meeting and the Evolution of the B...
GlobeNewswire
18/06
Sterling Digital Print Adds Second Canon varioPRINT iX Sheetfed Inkjet Press Just Months After First...
GlobeNewswire
18/06
Atsign Announces Evolution of Secure Remote Access Solution: Introducing NoPorts
GlobeNewswire
18/06
4DMT to Present Initial Interim 24-week Landmark Analysis from the 4D-150 Phase 2 PRISM Population E...
GlobeNewswire
13/06
Lantronix Wins 2024 IoT Evolution Asset Tracking Award for FOX3 Telematic Gateway
GlobeNewswire
08/06
4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion C...
GlobeNewswire
06/06
4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Mo...
GlobeNewswire
31/05
Invivyd Announces General Alignment with U.S. FDA on a Repeatable, Expedient Emergency Use Authoriza...
GlobeNewswire
30/05
4DMT to Present Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibro...